Fuan Pharmaceutical (Group) Co., Ltd.

300194

CNE1000011G4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
4.08 ^CNY	+0.25%		-0.49%	-6.85%

05-28	Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024	CI
05-27	Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	CI

Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020

April 29, 2021 at 03:44 pm

Fuan Pharmaceutical (Group) Co., Ltd. at its annual general meeting held on April 28, 2021, approved cash dividend/10 shares (tax included) of CNY 0.50000000 for the year 2020.

Latest news about Fuan Pharmaceutical (Group) Co., Ltd.

Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024	05-28	CI
Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	05-27	CI
Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	04-24	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Fuan Pharm Unit's Hemorrhage Drug Gets Registration Certificate from China's Drug Regulator	04-07	MT
Drugs of Fuan Pharma's Unit Passes Regulatory Evaluation	02-22	MT
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Fuan Pharma Unit Gets Marketing Approval for Two Drugs	23-06-26	MT
Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023	23-05-05	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-03-31	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Fuan Pharmaceutical Registers New Respiratory Drug	22-10-10	MT
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Fuan Pharmaceutical Co., Ltd. Announces Management Appointments	21-12-13	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Fuan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Fuan Pharmaceutical Co., Ltd.(XSEC:300194) dropped from S&P Global BMI Index	21-06-21	CI
Fuan Pharmaceutical Co., Ltd. Announces Implementation of Profit Distribution Plan for A Shares for the Year 2020, Payable on 14 May 2021	21-05-07	CI
Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020	21-04-29	CI
Fuan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI

Chart Fuan Pharmaceutical (Group) Co., Ltd.

Duration

Period

Chart Fuan Pharmaceutical (Group) Co., Ltd.

More charts

Fuan Pharmaceutical (Group) Co.,Ltd. is a China-based company principally engaged in the sales of Active Pharmaceutical Ingredients (APIs) and intermediates, preparations and pharmaceuticals. The Company's pharmaceutical products mainly include antibiotics, anti-tumor medicines, respiratory system medicines and specialty medicines. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
FUAN PHARMACEUTICAL (GROUP) CO., LTD.	-6.85%	670M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B